Concepedia

Attila Paczal

AP

Statistics

Publications

8

Citations

1.3K

H-Index

8

Active since

2006

Affiliations

Servier (France)(Current)

Institut des Hautes Études Scientifiques

Eötvös Loránd University

University of Debrecen

Attila Paczal is an author at Servier (France) specializing in medicine, drug discovery, and natural sciences.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesTumor BiologyRadiation OncologyMedicinal ChemistryOncologyChemistryEngineering

Publications per year

2006–2021

8

Publications

8

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1K citations

Mcl1 Inhibitor S63845, Systems Biology, Oncology +11

Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor

Zoltán Szlávik, Márton Csékei, Attila Paczal et al. · Journal of Medicinal Chemistry · 2020 · 97 citations · Full text

Molecular Docking, Tumor Biology, Medicinal Chemistry +14

Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity

Zoltán Szlávik, Levente Ondi, Márton Csékei et al. · Journal of Medicinal Chemistry · 2019 · 69 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +14

Modular Synthesis of Heterocyclic Carbene Precursors

Attila Paczal, Attila Bényei, András Kotschy · The Journal of Organic Chemistry · 2006 · 68 citations

Engineering, Heterocyclic Carbene Precursors, Heterocyclic +9

Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors

Csaba Wéber, Melinda Sipos, Attila Paczal et al. · Journal of Medicinal Chemistry · 2021 · 33 citations · Full text

1–5 of 8